secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001609550-25-000052
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q3 revenue $224.5M (+10% YoY); net income down; FY25 EPS guidance raised to $0.90-$1.00
--------------------------------------------------------------------------------

- Revenue $224.5M in Q3 2025, up 10% from $203.2M a year ago; U.S. revenue $214.4M (+9%), OUS revenue $10.1M (+37%).
- Gross margin 85.8% vs 84.1% YoY, driven by higher volume and Inspire V mix with lower COGS.
- Net income $9.9M ($0.34 diluted EPS) vs $18.5M ($0.60) prior year; adjusted diluted EPS $0.38.
- FY2025 revenue guidance reaffirmed $900M-$910M (12-13% growth); EPS guidance raised to $0.90-$1.00 from $0.40-$0.50.
- Completed $50M in share repurchases; Q3 operating cash flow $68.5M; cash & investments $410.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955025000052/0001609550-25-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955025000052/insp-20251103.htm
  HTML page:      https://secwatch.observer/filing/0001609550-25-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer